Study on reversible effect on muscle of the botulinica toxin on the prevention of the post-traumatic rigidity of elbow - TB2006

• Conditions: omero mono-Inter-sovra-sovraintercondiloidee fractures of distant them, fractures of capitello radial and fractures of olecrano with or without luxation; MedDRA version: 9.1Level: LLTClassification code 10028330Term: Muscle rigidity

• Registration Number: EUCTR2007-000919-29-IT
• Lead Sponsor: ISTITUTI ORTOPEDICI RIZZOLI

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-09-11
• Last Update Posted: 10 February 2014

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

They will come included patients with age comprised between 14 and 75 years, male sex and feminine without racial exclusion with omero mono-Inter-sovra-sovraintercondiloidee fractures it tos be distant them, fractures of capitello radial and fractures of olecrano with or without luxation.
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Neuromuscular (serious myasthenia and amiotrofica lateral sclerosis), association with aminoglicosidi, spectinomicina and curaroderivati diseases. Paralysis of whichever degree of the tricipite muscle.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified